Company: TAK
Filing Date: 2025-02-13
Form Type: 6-K
Source: 0001395064-25-000022
Chunk: 1

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-02-13
Form: 6-K
Chunk 1
---
(1) Status of repurchase pursuant to a resolution approved by a General Meeting of Shareholders
Not applicable

(2) Status of repurchase pursuant to a resolution approved by a meeting of the Board of Directors

|                                                                       |     |                           |     |   |   |     |   |                  |     | As of January 31, 2025 |
|:----------------------------------------------------------------------|:----|--------------------------:|:----|:--|:--|:----|:--|-----------------:|:----|:-----------------------|
|                                                                       |     | Number of shares (shares) |     |   |   |     |   | Total repurchase 
     amount (JPY) |     |                        |
| Status of the resolution of the Board of Directors (January 30, 2025) 
 (Period of repurchase: from February 17, 2025 to May 31, 2025)        |     |                28,500,000 |     |   |   |     |   |  100,000,000,000 |     |                        |
| Repurchases during this reporting month (Date of repurchase)          |     |                     -Date |     |   |   |     |   |                  |     |                        |
| —                                                                     |     |                           |     | — |   |     | — |                  |     |                        |
| Total                                                                 |     |                         — |     |   | — |     |   |                — |     |                        |
| Aggregate shares repurchased as of the end of this reporting month    |     |                         — |     |   |   |     |   |                — |     |                        |
| Progress of share repurchase (%)                                      |     |                         — |     |   |   |     |   |                — |     |                        |

(Note 1) The period of repurchase is listed on a trade date basis.

(Note 2) It was resolved at the above meeting of the Board of Directors that the method of acquisition shall be open-market repurchase through a trust bank.

2. Status of disposition

|                                                                          |     |                                 |     |            |     |                   |     | As of January 31, 2025 |
|:-------------------------------------------------------------------------|:----|--------------------------------:|:----|-----------:|:----|------------------:|:----|:-----------------------|
|                                                                          |     |       Number of shares disposed 
 in the reporting month (